Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 0

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 0
---
TABLE OF CONTENTS

Filed Pursuant to Rule 424(b)(2) Registration No. 333-285032 PROSPECTUS SUPPLEMENT
(To Prospectus dated February 18, 2025) €1,500,000,000 American Medical Systems Europe B.V. (incorporated as a private company with limited liability in the Netherlands with its statutory seat in Amsterdam, the Netherlands) €850,000,000 3.000% Senior Notes due 2031
€650,000,000 3.250% Senior Notes due 2034
Fully and Unconditionally Guaranteed by
Boston Scientific Corporation American Medical Systems Europe B.V. (“AMS Europe” or the “Issuer”), a wholly-owned finance subsidiary of Boston Scientific Corporation (“Boston Scientific” or the “guarantor”), is offering €850,000,000 aggregate principal amount of 3.000% senior notes due 2031 (the “2031 Notes”) and €650,000,000 aggregate principal amount of 3.250% senior notes due 2034 (the “2034 Notes” and, together with the 2031 Notes, the “notes”). AMS Europe will pay interest on the notes on March 8 of each year, beginning March 8, 2026. We intend to use the net proceeds from this offering, together with cash on hand, to fund the repayment at maturity of AMS Europe’s 0.750% Senior Notes due March 8, 2025 (the “March 2025 Notes”), of which €1,000 million aggregate principal amount was outstanding as of the date of this prospectus supplement, and to pay accrued and unpaid interest with respect to such notes, and for general corporate purposes, which may include, among other things, short term investments, reduction of short term debt, funding of working capital and potential future acquisitions. AMS Europe may redeem the notes of each series in whole at any time or in part from time to time at the redemption prices described under the heading “Description of the Notes — Optional Redemption” in this prospectus supplement. There are no sinking funds for the notes. AMS Europe will be required to offer to repurchase the notes upon the occurrence of a Change of Control Repurchase Event (as defined herein). The notes will be senior unsecured obligations of AMS Europe, will rank equally in right of payment with all of AMS Europe’s other existing and future unsecured and unsubordinated indebtedness and be senior to any future indebtedness of AMS Europe that is